Kilitch Drugs (India) Limited has informed the Exchange about Copy of Newspaper Publication
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has published the Basis of Allotment of its Rights Issue in newspapers, as required under SEBI rules. The company issued 13,98,463 equity shares of face value ₹10 each at ₹357 per share (including ₹347 premium), aggregating to ₹4,992.51 lakhs, in the ratio of 2 rights shares for every 23 shares held, with the record date being July 15, 2025. The issue, which opened on July 23, 2025 and closed on August 21, 2025, received 2,416 applications for 16,69,993 shares, of which 396 were technically rejected, leaving 2,020 valid applications subscribing to 16,52,926 shares — an oversubscription of 118.20% of the issue size. The Board approved the allotment on August 22, 2025, and trading of the newly issued shares is expected to commence on August 26, 2025 on both BSE and NSE.
The Rights Issue was oversubscribed at 118.20%, reflecting decent investor interest and confidence in the company. Shareholders should expect allotment credits and trading in new shares starting August 26, 2025, which will increase share count by roughly 8.7% and modestly dilute existing holdings, while bringing in about ₹49.93 crore of fresh capital for the company.